Attenzione: i dati modificati non sono ancora stati salvati. Per confermare inserimenti o cancellazioni di voci è necessario confermare con il tasto INSERISCI in fondo alla pagina
CINECA IRIS Institutional Research Information System
Abstract
BACKGROUND:
Underweight and severe and morbid obesity are associated with highly elevated risks of adverse health outcomes. We estimated trends in mean body-mass index (BMI), which characterises its population distribution, and in the prevalences of a complete set of BMI categories for adults in all countries.
METHODS:
We analysed, with use of a consistent protocol, population-based studies that had measured height and weight in adults aged 18 years and older. We applied a Bayesian hierarchical model to these data to estimate trends from 1975 to 2014 in mean BMI and in the prevalences of BMI categories (<18·5 kg/m(2) [underweight], 18·5 kg/m(2) to <20 kg/m(2), 20 kg/m(2) to <25 kg/m(2), 25 kg/m(2) to <30 kg/m(2), 30 kg/m(2) to <35 kg/m(2), 35 kg/m(2) to <40 kg/m(2), ≥40 kg/m(2) [morbid obesity]), by sex in 200 countries and territories, organised in 21 regions. We calculated the posterior probability of meeting the target of halting by 2025 the rise in obesity at its 2010 levels, if post-2000 trends continue.
FINDINGS:
We used 1698 population-based data sources, with more than 19·2 million adult participants (9·9 million men and 9·3 million women) in 186 of 200 countries for which estimates were made. Global age-standardised mean BMI increased from 21·7 kg/m(2) (95% credible interval 21·3-22·1) in 1975 to 24·2 kg/m(2) (24·0-24·4) in 2014 in men, and from 22·1 kg/m(2) (21·7-22·5) in 1975 to 24·4 kg/m(2) (24·2-24·6) in 2014 in women. Regional mean BMIs in 2014 for men ranged from 21·4 kg/m(2) in central Africa and south Asia to 29·2 kg/m(2) (28·6-29·8) in Polynesia and Micronesia; for women the range was from 21·8 kg/m(2) (21·4-22·3) in south Asia to 32·2 kg/m(2) (31·5-32·8) in Polynesia and Micronesia. Over these four decades, age-standardised global prevalence of underweight decreased from 13·8% (10·5-17·4) to 8·8% (7·4-10·3) in men and from 14·6% (11·6-17·9) to 9·7% (8·3-11·1) in women. South Asia had the highest prevalence of underweight in 2014, 23·4% (17·8-29·2) in men and 24·0% (18·9-29·3) in women. Age-standardised prevalence of obesity increased from 3·2% (2·4-4·1) in 1975 to 10·8% (9·7-12·0) in 2014 in men, and from 6·4% (5·1-7·8) to 14·9% (13·6-16·1) in women. 2·3% (2·0-2·7) of the world's men and 5·0% (4·4-5·6) of women were severely obese (ie, have BMI ≥35 kg/m(2)). Globally, prevalence of morbid obesity was 0·64% (0·46-0·86) in men and 1·6% (1·3-1·9) in women.
INTERPRETATION:
If post-2000 trends continue, the probability of meeting the global obesity target is virtually zero. Rather, if these trends continue, by 2025, global obesity prevalence will reach 18% in men and surpass 21% in women; severe obesity will surpass 6% in men and 9% in women. Nonetheless, underweight remains prevalent in the world's poorest regions, especially in south Asia.
Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 19·2 million participants
Abstract
BACKGROUND:
Underweight and severe and morbid obesity are associated with highly elevated risks of adverse health outcomes. We estimated trends in mean body-mass index (BMI), which characterises its population distribution, and in the prevalences of a complete set of BMI categories for adults in all countries.
METHODS:
We analysed, with use of a consistent protocol, population-based studies that had measured height and weight in adults aged 18 years and older. We applied a Bayesian hierarchical model to these data to estimate trends from 1975 to 2014 in mean BMI and in the prevalences of BMI categories (<18·5 kg/m(2) [underweight], 18·5 kg/m(2) to <20 kg/m(2), 20 kg/m(2) to <25 kg/m(2), 25 kg/m(2) to <30 kg/m(2), 30 kg/m(2) to <35 kg/m(2), 35 kg/m(2) to <40 kg/m(2), ≥40 kg/m(2) [morbid obesity]), by sex in 200 countries and territories, organised in 21 regions. We calculated the posterior probability of meeting the target of halting by 2025 the rise in obesity at its 2010 levels, if post-2000 trends continue.
FINDINGS:
We used 1698 population-based data sources, with more than 19·2 million adult participants (9·9 million men and 9·3 million women) in 186 of 200 countries for which estimates were made. Global age-standardised mean BMI increased from 21·7 kg/m(2) (95% credible interval 21·3-22·1) in 1975 to 24·2 kg/m(2) (24·0-24·4) in 2014 in men, and from 22·1 kg/m(2) (21·7-22·5) in 1975 to 24·4 kg/m(2) (24·2-24·6) in 2014 in women. Regional mean BMIs in 2014 for men ranged from 21·4 kg/m(2) in central Africa and south Asia to 29·2 kg/m(2) (28·6-29·8) in Polynesia and Micronesia; for women the range was from 21·8 kg/m(2) (21·4-22·3) in south Asia to 32·2 kg/m(2) (31·5-32·8) in Polynesia and Micronesia. Over these four decades, age-standardised global prevalence of underweight decreased from 13·8% (10·5-17·4) to 8·8% (7·4-10·3) in men and from 14·6% (11·6-17·9) to 9·7% (8·3-11·1) in women. South Asia had the highest prevalence of underweight in 2014, 23·4% (17·8-29·2) in men and 24·0% (18·9-29·3) in women. Age-standardised prevalence of obesity increased from 3·2% (2·4-4·1) in 1975 to 10·8% (9·7-12·0) in 2014 in men, and from 6·4% (5·1-7·8) to 14·9% (13·6-16·1) in women. 2·3% (2·0-2·7) of the world's men and 5·0% (4·4-5·6) of women were severely obese (ie, have BMI ≥35 kg/m(2)). Globally, prevalence of morbid obesity was 0·64% (0·46-0·86) in men and 1·6% (1·3-1·9) in women.
INTERPRETATION:
If post-2000 trends continue, the probability of meeting the global obesity target is virtually zero. Rather, if these trends continue, by 2025, global obesity prevalence will reach 18% in men and surpass 21% in women; severe obesity will surpass 6% in men and 9% in women. Nonetheless, underweight remains prevalent in the world's poorest regions, especially in south Asia.
Adolescent; Adult; Bayes Theorem; Developed Countries; Developing Countries; Female; Forecasting; Humans; Male; Models, Statistical; Obesity; Prevalence; Thinness; Young Adult; Body Mass Index; Global Health; Medicine (all)
NCD Risk Factor Collaboration including; Di Cesare M; Bentham J; Stevens GA; Zhou B; Danaei G; Lu Y; Bixby H; Cowan MJ; Riley LM; Hajifathalian K; Fortunato L; Taddei C; Bennett JE; Ikeda N; Khang YH; Kyobutungi C; Laxmaiah A; Li Y; Lin HH; Miranda JJ; Mostafa A; Turley ML; Paciorek CJ; Gunter M; Ezzati M; Abdeen ZA; Abdul Hamid Z; Abu-Rmeileh NM; Acosta-Cazares B; Adams R; Aekplakorn W; Aguilar-Salinas CA; Ahmadvand A; Ahrens W; Ali MM; Alkerwi A; Alvarez-Pedrerol M; Aly E; Amouyel P; Amuzu A; Andersen LB; Anderssen SA; Andrade DS; Anjana RM; Aounallah-Skhiri H; Ariansen I; Aris T; Arlappa N; Arveiler D; Assah FK; Avdicová M; Azizi F; Beheshti S; Babu BV; Balakrishna N; Bandosz P; Banegas JR; Barbagallo CM; Barceló A; Barkat A; Barros MV; Bata I; Batieha AM; Batista RL; Baur LA; Beaglehole R; Ben Romdhane H; Benet M; Bernabe-Ortiz A; Bernotiene G; Bettiol H; Bhagyalaxmi A; Bharadwaj S; Bhargava SK; Bhatti Z; Bhutta ZA; Bi H; Bi Y; Bjerregaard P; Bjertness E; Bjertness MB; Björkelund C; Blake M; Blokstra A; Bo S; Bobak M; Boddy LM; Boehm BO; Boeing H; Boissonnet CP; Bongard V; Bovet P; Braeckman L; Bragt MC; Brajkovich I; Branca F; Breckenkamp J; Brenner H; Brewster LM; Brian GR; Bruno G; Bueno-de-Mesquita HB; Bugge A; Burns C; Cabrera de León A; Cacciottolo J; Cama T; Cameron C; Camolas J; Can G; Cândido AP; Capuano V; Cardoso VC; Carvalho MJ; Casanueva F; Casas JP; Caserta CA; Castetbon K; Chamukuttan S; Chan AW; Chan Q; Chaturvedi HK; Chaturvedi N; Chen CJ; Chen F; Chen H; Chen S; Chen Z; Cheng CY; Chetrit A; Chiolero A; Chiou ST; Chirita-Emandi A; Cho Y; Christensen K; Chudek J; Cifkova R; Claessens F; Clays E; Concin H; Cooper C; Cooper R; Coppinger TC; Costanzo S; Cottel D; Cowell C; Craig CL; Crujeiras AB; D'Arrigo G; d'Orsi E; Dallongeville J; Damasceno A; Damsgaard CT; Danaei G; Dankner R; Dauchet L; De Backer G; De Bacquer D; de Gaetano G; De Henauw S; De Smedt D; Deepa M; Deev AD; Dehghan A; Delisle H; Delpeuch F; Dhana K; Di Castelnuovo AF; Dias-da-Costa JS; Diaz A; Djalalinia S; Do HT; Dobson AJ; Donfrancesco C; Döring A; Doua K; Drygas W; Egbagbe EE; Eggertsen R; Ekelund U; El Ati J; Elliott P; Engle-Stone R; Erasmus RT; Erem C; Eriksen L; Escobedo-de la Peña J; Evans A; Faeh D; Fall CH; Farzadfar F; Felix-Redondo FJ; Ferguson TS; Fernández-Bergés D; Ferrante D; Ferrari M; Ferreccio C; Ferrieres J; Finn JD; Fischer K; Flores EM; Föger B; Foo LH; Forslund AS; Fortmann SP; Fouad HM; Francis DK; Franco Mdo C; Franco OH; Frontera G; Fuchs FD; Fuchs SC; Fujita Y; Furusawa T; Gaciong Z; Gafencu M; Gareta D; Garnett SP; Gaspoz JM; Gasull M; Gates L; Geleijnse JM; Ghasemian A; Giampaoli S; Gianfagna F; Giovannelli J; Giwercman A; Goldsmith RA; Gonzalez Gross M; González Rivas JP; Gorbea MB; Gottrand F; Graff -Iversen S; Grafnetter D; Grajda A; Grammatikopoulou MG; Gregor RD; Grodzicki T; Grøntved A; Gruden G; Grujic V; Gu D; Guan OP; Gudnason V; Guerrero R; Guessous I; Guimaraes AL; Gulliford MC; Gunnlaugsdottir J; Gunter M; Guo XH; Guo Y; Gupta PC; Gureje O; Gurzkowska B; Gutierrez L; Gutzwiller F; Halkjær J; Hardy R; Hari Kumar R; Hayes AJ; He J; Hendriks ME; Hernandez Cadena L; Heshmat R; Hihtaniemi IT; Ho SY; Ho SC; Hobbs M; Hofman A; Hormiga CM; Horta BL; Houti L; Htay TT; Htet AS; Htike MM; Hu Y; Hussieni AS; Huu CN; Huybrechts I; Hwalla N; Iacoviello L; Iannone AG; Ibrahim MM; Ikeda N; Ikram MA; Irazola VE; Islam M; Iwasaki M; Jackson RT; Jacobs JM; Jafar T; Jamil KM; Jamrozik K; Jasienska G; Jiang CQ; Joffres M; Johansson M; Jonas JB; Jørgensen T; Joshi P; Juolevi A; Jurak G; Jureša V; Kaaks R; Kafatos A; Kalter-Leibovici O; Kapantais E; Kasaeian A; Katz J; Kaur P; Kavousi M; Keil U; Keinan Boker L; Kelishadi R; Kemper H; Kengne AP; Kersting M; Key T; Khader YS; Khalili D; Khang YH; Khaw KT; Khouw IM; Kiechl S; Killewo J; Kim J; Kiyohara Y; Klimont J; Kolle E; Kolsteren P; Korrovits P; Koskinen S; Kouda K; Koziel S; Kratzer W; Krokstad S; Kromhout D; Kruger HS; Kula K; Kulaga Z; Kumar RK; Kusuma YS; Kuulasmaa K; Kyobutungi C; Laamiri FZ; Laatikainen T; Lachat C; Laid Y; Lam TH; Landrove O; Lanska V; Lappas G; Laugsand LE; Laxmaiah A; Le Nguyen Bao K; Le TD; Leclercq C; Lee J; Lee J; Lehtimäki T; Lekhraj R; León-Muñoz LM; Li Y; Lim WY; Lima-Costa MF; Lin HH; Lin X; Linneberg A; Lissner L; Litwin M; Liu J; Lorbeer R; Lotufo PA; Lozano JE; Luksiene D; Lundqvist A; Lunet N; Lytsy P; Ma G; Machi S; Maggi S; Magliano DJ; Makdisse M; Malekzadeh R; Malhotra R; Mallikharjuna Rao K; Manios Y; Mann J; Manzato E; Margozzini P; Markey O; Marques-Vidal P; Marrugat J; Martin-Prevel Y; Martorell R; Masoodi SR; Matsha TE; Mazur A; Mbanya JC; McFarlane SR; McGarvey ST; McKee M; McLachlan S; McLean RM; McNulty BA; Md Yusof S; Mediene-Benchekor S; Meirhaeghe A; Meisinger C; Mendes LL; Menezes AM; Mensink GB; Meshram II; Metspalu A; Mi J; Michaelsen KF; Mikkel K; Miller JC; Miquel JF; Miranda JJ; Mišigoj-Duraković M; Mohamed MK; Mohammad K; Mohammadifard N; Mohan V; Mohd Yusoff MF; Molbo D; Møller NC; Molnár D; Mondo CK; Monterrubio EA; Monyeki KD; Moreira LB; Morejon A; Moreno LA; Morgan K; Mortensen EL; Moschonis G; Mossakowska M; Mostafa A; Mota J; Motlagh ME; Motta J; Mu TT; Muiesan ML; Müller-Nurasyid M; Murphy N; Mursu J; Murtagh EM; Musa KI; Musil V; Nagel G; Nakamura H; Námešná J; Nang EE; Nangia VB; Nankap M; Narake S; Navarrete-Muñoz EM; Nenko I; Neovius M; Nervi F; Neuhauser HK; Nguyen ND; Nguyen QN; Nieto-Martínez RE; Ning G; Ninomiya T; Nishtar S; Noale M; Norat T; Noto D; Nsour MA; O'Reilly D; Ochoa-Avilés AM; Oh K; Olayan IH; Olinto MT; Oltarzewski M; Omar M; Onat A; Ordunez P; Ortiz AP; Osler M; Osmond C; Ostojic SM; Otero JA; Overvad K; Paccaud FM; Padez C; Pajak A; Palli D; Palloni A; Palmieri L; Panda-Jonas S; Panza F; Parnell WR; Parsaeian M; Pednekar MS; Peeters PH; Peixoto SV; Pereira AC; Pérez CM; Peters A; Peykari N; Pham ST; Pigeot I; Pikhart H; Pilav A; Pilotto L; Pistelli F; Pitakaka F; Piwonska A; Piwonski J; Plans-Rubió P; Poh BK; Porta M; Portegies ML; Poulimeneas D; Pradeepa R; Prashant M; Price JF; Puiu M; Punab M; Qasrawi RF; Qorbani M; Quoc Bao T; Radic I; Radisauskas R; Rahman M; Raitakari O; Raj M; Ramachandra Rao S; Ramachandran A; Ramke J; Ramos R; Rampal S; Rasmussen F; Redon J; Reganit PF; Ribeiro R; Riboli E; Rigo F; Rinke de Wit TF; Ritti-Dias RM; Rivera JA; Robinson SM; Robitaille C; Rodríguez-Artalejo F; Rodriguez-Perez Mdel C; Rodríguez-Villamizar LA; Rojas-Martinez R; Rojroongwasinkul N; Romaguera D; Ronkainen K; Rosengren A; Rouse I; Rubinstein A; Rühli FJ; Rui O; Ruiz-Betancourt BS; Russo Horimoto AR; Rutkowski M; Sabanayagam C; Sachdev HS; Saidi O; Salanave B; Salazar Martinez E; Salomaa V; Salonen JT; Salvetti M; Sánchez-Abanto J; Sandjaja; Sans S; Santos DA; Santos O; dos Santos RN; Santos R; Sardinha LB; Sarrafzadegan N; Saum KU; Savva SC; Scazufca M; Schaffrath Rosario A; Schargrodsky H; Schienkiewitz A; Schmidt IM; Schneider IJ; Schultsz C; Schutte AE; Sein AA; Senbanjo IO; Sepanlou SG; Shalnova SA; Shaw JE; Shibuya K; Shin Y; Shiri R; Siantar R; Sibai AM; Silva AM; Silva DA; Simon M; Simons J; Simons LA; Sjostrom M; Slowikowska-Hilczer J; Slusarczyk P; Smeeth L; Smith MC; Snijder MB; So HK; Sobngwi E; Söderberg S; Soekatri MY; Solfrizzi V; Sonestedt E; Sørensen TI; Sorić M; Sossa Jérome C; Soumare A; Staessen JA; Starc G; Stathopoulou MG; Staub K; Stavreski B; Steene-Johannessen J; Stehle P; Stein AD; Stergiou GS; Stessman J; Stieber J; Stöckl D; Stocks T; Stokwiszewski J; Stratton G; Strufaldi MW; Sun CA; Sundström J; Sung YT; Sunyer J; Suriyawongpaisal P; Swinburn B; Sy RG; Szponar L; Tai ES; Tammesoo ML; Tamosiunas A; Tang L; Tang X; Tanser F; Tao Y; Tarawneh M; Tarp J; Tarqui-Mamani CB; Taylor A; Tchibindat F; Thijs L; Thuesen BH; Tjonneland A; Tolonen HK; Tolstrup JS; Topbas M; Topór-Madry R; Torrent M; Traissac P; Trichopoulou A; Trichopoulos D; Trinh OT; Trivedi A; Tshepo L; Tulloch-Reid MK; Tuomainen TP; Tuomilehto J; Turley ML; Tynelius P; Tzotzas T; Tzourio C; Ueda P; Ukoli FA; Ulmer H; Unal B; Valdivia G; Vale S; Valvi D; van der Schouw YT; Van Herck K; Van Minh H; van Valkengoed IG; Vanderschueren D; Vanuzzo D; Vatten L; Vega T; Velasquez-Melendez G; Veronesi G; Verschuren WM; Viegi G; Viet L; Viikari-Juntura E; Vineis P; Vioque J; Virtanen JK; Visvikis-Siest S; Viswanathan B; Vollenweider P; Voutilainen S; Vrijheid M; Wade AN; Wagner A; Walton J; Wan N; Wan M; Wang MD; Wang Q; Wang YX; Wannamethee SG; Wareham N; Weerasekera D; Whincup PH; Widhalm K; Widyahening I; Wiecek A; Wilks RJ; Willeit J; Wojtyniak B; Wong JE; Wong TY; Woo J; Woodward M; Wu FC; Wu J; Wu SL; Xu H; Xu L; Yamborisut U; Yan W; Yang X; Yardim N; Ye X; Yiallouros PK; Yoshihara A; You QS; Younger-Coleman NO; Yusoff AF; Zainuddin A; Zambon S; Zdrojewski T; Zeng Y; Zhao D; Zhao W; Zheng Y; Zhou M; Zhu D; Zimmermann E; Zuñiga Cisneros J.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1562847
Citazioni
1823
3707
2938
social impact
Conferma cancellazione
Sei sicuro che questo prodotto debba essere cancellato?
simulazione ASN
Il report seguente simula gli indicatori relativi alla produzione scientifica in relazione alle soglie ASN 2023-2025 del proprio SC/SSD. Si ricorda che il superamento dei valori soglia (almeno 2 su 3) è requisito necessario ma non sufficiente al conseguimento dell'abilitazione.
La simulazione si basa sui dati IRIS e presenta gli indicatori calcolati alla data indicata sul report. Si ricorda che in sede di domanda ASN presso il MIUR gli indicatori saranno invece calcolati a partire dal 1° gennaio rispettivamente del quinto/decimo/quindicesimo anno precedente la scadenza del quadrimestre di presentazione della domanda (art 2 del DM 598/2018).
In questa simulazione pertanto il valore degli indicatori potrà differire da quello conteggiato all’atto della domanda ASN effettuata presso il MIUR a seguito di:
Correzioni imputabili a eventuali periodi di congedo obbligatorio, che in sede di domanda ASN danno diritto a incrementi percentuali dei valori.
Presenza di eventuali errori di catalogazione e/o dati mancanti in IRIS
Variabilità nel tempo dei valori citazionali (per i settori bibliometrici)
Variabilità della finestra temporale considerata in funzione della sessione di domanda ASN a cui si partecipa.
La presente simulazione è stata realizzata sulla base delle regole riportate nel DM 598/2018 e dell'allegata Tabella A e delle specifiche definite all'interno del Focus Group Cineca relativo al modulo IRIS ER. Il Cineca non si assume alcuna responsabilità in merito all'uso che il diretto interessato o terzi faranno della simulazione.